Implementation Guidelines - Federal Transit Administration - U.S. ...
Implementation Guidelines - Federal Transit Administration - U.S. ... Implementation Guidelines - Federal Transit Administration - U.S. ...
The following laboratories are voluntarily withdrawing from the NLCP: Withdrawal effective November 1, 2001: Dept. of the Navy, Navy Drug Screening Laboratory, Great Lakes, IL Building 38H, P. O. Box 88-6819 Great Lakes, IL 60088-6819 847-688-2045 / 847-688-4171 Withdrawal effective October 1, 2001: Quest Diagnostics Incorporated 801 East Dixie Ave., Suite 105A Leesburg, FL 34748 352-787-9006x4343 (Formerly: SmithKline Beecham Clinical Laboratories, Doctors & Physicians Laboratory) Withdrawal effective October 1, 2001: Quest Diagnostics Incorporated 4444 Giddings Road Auburn Hills, MI 48326 248-373-9120 / 800-444-0106 (Formerly: HealthCare/Preferred Laboratories, HealthCare/MetPath, CORNING Clinical Laboratories) Withdrawal effective October 1, 2001: Quest Diagnostics Incorporated One Malcomb Ave. Teterboro, NJ 07608 201-393-5590 (Formerly: MetPath, Inc., CORNING MetPath Clinical Laboratories, CORNING Clinical Laboratory) *The Standards Council of Canada (SCC) voted to end its Laboratory Accreditation Program for Substance Abuse (LAPSA) effective May 12, 1998. Laboratories certified through that program were accredited to conduct forensic urine drug testing as required by U.S. Department of Transportation (DOT) regulations. As of that date, the certification of those accredited Canadian laboratories will continue under DOT authority. The responsibility for conducting quarterly performance testing plus periodic on-site inspections of those LAPSA-accredited laboratories was transferred to the U.S. DHHS, with the DHHS' National Laboratory Certification Program (NLCP) contractor continuing to have an active role in the performance testing and laboratory inspection processes. Other Canadian laboratories wishing to be considered for the NLCP may apply directly to the NLCP contractor just as U.S. laboratories do. Upon finding a Canadian laboratory to be qualified, the DHHS will recommend that DOT certify the laboratory (Federal Register, 16 July 1996) as meeting the minimum standards of the "Mandatory Guidelines for Workplace Drug Testing" (59 Federal Register, 9 June 1994, Pages 29908-29931). After receiving the DOT certification, the laboratory will be included in the monthly list of DHHS certified laboratories and participate in the NLCP certification maintenance program. Appendix D. Certified Laboratories D-7 August 2002
Appendix E Conforming Products List of Evidential Breath Measurement Devices
- Page 256 and 257: Chapter 13. THE DRUG-FREE WORKPLACE
- Page 258 and 259: Violations of the act may result in
- Page 260 and 261: Exhibit 13-1 DRUG-FREE WORKPLACE AC
- Page 262 and 263: Chapter 14. SUBSTANCE ABUSE MANAGEM
- Page 264 and 265: Notification of audit Requested mat
- Page 266 and 267: them to move throughout the facilit
- Page 268 and 269: above materials. ⎯⎯Procedures t
- Page 270 and 271: DAY 3 Time Activity Team Address of
- Page 272 and 273: Date of Collection Jan-01 Nov-00 Se
- Page 274 and 275: Time of the Test Time of the Test 8
- Page 276 and 277: Each auditor will discuss the porti
- Page 278 and 279: Sample Re-audit Agenda DAY 1 Time A
- Page 280 and 281: Index of Appendices Appendix A. Acr
- Page 282 and 283: AA Alcoholics Anonymous Appendix A.
- Page 284 and 285: RFP Request for Proposal RIA Radio
- Page 286 and 287: Newsletters Appendix B. Additional
- Page 288 and 289: U.S. Department of Labor. What Work
- Page 290 and 291: Other Government Web sites Drug and
- Page 292 and 293: Appendix C Americans with Disabilit
- Page 294 and 295: sensitive duties for the illegal us
- Page 296 and 297: If the individual is qualified and
- Page 298 and 299: allegation of discrimination under
- Page 300 and 301: Appendix D. Certified Laboratories
- Page 302 and 303: DrugProof, Divison of Dynacare 543
- Page 304 and 305: One Source Toxicology Laboratory, I
- Page 308 and 309: Federal Register / Vol. 65, No. 141
- Page 310 and 311: Federal Register / Vol. 65, No. 141
- Page 312 and 313: Federal Register / Vol. 65, No. 141
- Page 314 and 315: Appendix F. Fact Sheets Drug Detect
- Page 316 and 317: Social Issues • Two-thirds of all
- Page 318 and 319: • The euphoric stimulation increa
- Page 320 and 321: • Paranoia • Profuse sweating a
- Page 322 and 323: connection between marijuana smokin
- Page 324 and 325: Opiates (Narcotics) Fact Sheet Opia
- Page 326 and 327: Phencyclidine (PCP) Fact Sheet Phen
- Page 328 and 329: Appendix G Questions and Answers
- Page 330 and 331: ecipient, and someone other than th
- Page 332 and 333: Q. Can transit operators receive wa
- Page 334 and 335: Q. If an employee changed jobs prio
- Page 336 and 337: Q. How much training are employers
- Page 338 and 339: acceptable for the company-required
- Page 340 and 341: Q. In a post-accident situation req
- Page 342 and 343: employees and 50 non-DOT employees,
- Page 344 and 345: Q: What actual address is required
- Page 346 and 347: Q: Can a split specimen be sent to
- Page 348 and 349: actual employee of the employer may
- Page 350 and 351: Q: Must collectors, BATs, STTs, MRO
- Page 352 and 353: an observer, or a monitor for co-wo
- Page 354 and 355: Q: If a collector makes an error on
Appendix E<br />
Conforming Products List of Evidential Breath<br />
Measurement Devices
Change language